EV/EBITDA
-0.69
0.000.00%
Sat, 01 Mar 2025 00:56:51 GMT
Summary
- As of March 3, 2025, TCRX EV/EBITDA is -0.69, unchanged from the previous trading day.
- Over the past year, TCRX EV/EBITDA has increased by +2.98 (+81.20%).
- TCRX EV/EBITDA is now -136.51% below its all-time high of 1.89.
Performance
TCRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TCRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +22.5% | -22.3% | -15.2% |
| 3 m3 months | +66.3% | -66.4% | -55.2% |
| 6 m6 months | +70.8% | -70.8% | -62.7% |
| ytdytd | +45.2% | -45.4% | -34.1% |
| 1 y1 year | +81.2% | -75.9% | -71.3% |
| 5 y5 years | - | - | - |
TCRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.8% | -1.00 | +31.0% | |
| 3 m | 3-month | -0.64 | -7.8% | -2.22 | +68.9% |
| 6 m | 6-month | -0.64 | -7.8% | -2.63 | +73.8% |
| 1 y | 1-year | -0.64 | -7.8% | -5.06 | +86.4% |
| 3 y | 3-year | 1.89 | -136.5% | -5.06 | +86.4% |
| 5 y | 5-year | 1.89 | -136.5% | -7.05 | +90.2% |
| alltime | all time | 1.89 | -136.5% | -7.05 | +90.2% |
TScan Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.69(-45.2%) |
| 2024 | -1.26(-59.5%) |
| Date | Value |
|---|---|
| 2023 | -3.11(+3355.6%) |
| 2022 | -0.09(-108.6%) |
| 2021 | 1.05 |
FAQ
- What is TScan Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TScan Therapeutics?
- What is TCRX EV/EBITDA year-to-date change?
- What is TScan Therapeutics EV/EBITDA year-on-year change?
What is TScan Therapeutics EV/EBITDA?
The current EV/EBITDA of TCRX is -0.69
What is the all time high EV/EBITDA for TScan Therapeutics?
TScan Therapeutics all-time high EV/EBITDA is 1.89
What is TCRX EV/EBITDA year-to-date change?
TScan Therapeutics EV/EBITDA has changed by +0.57 (+45.24%) since the beginning of the year
What is TScan Therapeutics EV/EBITDA year-on-year change?
Over the past year, TCRX EV/EBITDA has changed by +2.98 (+81.20%)